Mebendazole is unique among tubulin-active drugs in activating the MEK–ERK pathway

We recently showed that the anti-helminthic compound mebendazole (MBZ) has immunomodulating activity in monocyte/macrophage models and induces ERK signalling. In the present study we investigated whether MBZ induced ERK activation is shared by other tubulin binding agents (TBAs) and if it is observa...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Sci Rep
Main Authors: Andersson, Claes R., Selvin, Tove, Blom, Kristin, Rubin, Jenny, Berglund, Malin, Jarvius, Malin, Lenhammar, Lena, Parrow, Vendela, Loskog, Angelica, Fryknäs, Mårten, Nygren, Peter, Larsson, Rolf
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group UK 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7403428/
https://ncbi.nlm.nih.gov/pubmed/32753665
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-68986-0
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares